Screening at 45

With no one left behind

New Zealand has started lowering the bowel screening age. We’re calling for the next step – screening from 45, with earlier access for Māori and Pacific peoples.

Bowel screening saves lives. It can find bowel cancer before symptoms develop, when it is more likely to be successfully treated, and can even prevent cancer by finding and removing precancerous polyps.

The National Bowel Screening Programme now covers people aged 56–74 – bringing more than 250,000 additional New Zealanders into the programme compared with screening from 60.

But there is more to do.

Bowel Cancer New Zealand is calling for bowel screening from age 45 for all New Zealanders, with screening from age 35 for Māori and Pacific peoples.

Our updated modelling shows this could extend the protection of bowel screening to another 877,000 New Zealanders.

Why 45?

Bowel cancer is New Zealand’s second-highest cause of cancer death, taking more than 1,200 lives each year. It is also the leading cause of cancer death for New Zealanders under 50.

Our bowel cancer outcomes also lag behind Australia, where screening starts at 45. Research has identified around 410 more bowel cancer deaths in New Zealand each year than if we had Australia’s mortality rates.

In the 2023 election campaign, both National and Labour leaders committed to lowering New Zealand’s bowel screening age to match Australia. Screening has since moved from 60 to 56 – but New Zealand has not yet reached 45.

What difference could earlier screening make?

We’ve updated our modelling to look at what screening from 45 – alongside earlier screening for Māori and Pacific peoples – could mean for New Zealand.

Compared with the current programme starting at 56, we estimate that each year it could mean:

  • 877,000more New Zealanders covered by bowel screening
  • 366more bowel cancers detected through screening, before symptoms develop
  • 102more cancers diagnosed at Stage 1 rather than at a later stage
  • 4,487more people having precancerous polyps removed, helping to prevent bowel cancer from developing

Finding bowel cancer earlier makes a big difference. Around four in ten cancers found through bowel screening are diagnosed at Stage 1, compared with around one in ten cancers diagnosed after symptoms develop.

4 in 10found through bowel screening are diagnosed at Stage 1
1 in 10diagnosed after symptoms develop are diagnosed at Stage 1

No one should be left behind

A single screening age does not provide equal protection for everyone.

The younger age structure of the Māori population means bowel cancer cases peak around 10 years earlier than in non-Māori. Māori and Pacific peoples also experience poorer survival following a bowel cancer diagnosis.

That’s why we’re calling for screening from 35 for Māori and Pacific peoples, alongside screening from 45 for everyone else.

Earlier screening would help ensure Māori and Pacific peoples can benefit from bowel screening at an age that better reflects when bowel cancer affects their communities.

Can New Zealand afford to screen from 45?

Our modelling shows that there is a pathway to make it happen.

Screening from 45, together with screening Māori and Pacific peoples from 35, would require around 5,800 additional publicly funded colonoscopies each year compared with the current programme starting at 56.

At the same time, New Zealand has introduced FIT for Symptomatic, changing the way people with bowel cancer symptoms are assessed.

FIT helps identify which people with symptoms are most likely to need a colonoscopy, allowing colonoscopies to be targeted more effectively.

Our modelling estimates this change could free around 17,700 colonoscopies each year, with a modelled range of approximately 9,800–21,900. Even at the lower end of that range, this is more than the additional 5,800 colonoscopies estimated to be needed for earlier screening.

Needed for earlier screening~5,800
Freed by FIT for Symptomatic~17,700
Colonoscopies each year. Striped area shows the modelled range, approximately 9,800–21,900.

What would it cost?

$33.8ma year to expand the programme, before savings are considered
$39ma year saved through fewer colonoscopies with FIT for Symptomatic (central estimate)
$5.2mnet saving a year (central estimate)

Before savings are considered, we estimate expanding the programme would cost approximately $33.8 million a year.

Our central estimate is that the reduction in colonoscopies through FIT for Symptomatic could save approximately $39 million a year.

Taken together, the central estimate is a net saving of $5.2 million a year. Because modelling always involves uncertainty, we have also calculated a range – from an additional cost of $13 million to a saving of $15 million a year.

These figures also don't capture all the additional savings that come from preventing bowel cancers or diagnosing them at an earlier stage.

Read the evidence

We developed our proposals with input from our medical advisors and updated our modelling following engagement with health officials.

We first presented our proposals to the Health Minister in February 2025 and have more recently shared them with political parties ahead of the 2026 election.

The reports below set out the evidence behind our call for change, including the expected health benefits, costs and colonoscopy capacity impacts.

Add your voice

New Zealand has started lowering the bowel screening age. Now we need a clear plan to get to 45, with no one left behind.

Find out what we're asking political parties to commit to ahead of the 2026 election and how you can add your voice.